Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC

Authors:

Top Cited Papers
Open Access
Abstract
No abstract available
Funding Information
  • University of Chicago

This publication has 33 references indexed in Scilit: